/**
 * Phase H.UI v3: Suggestion Engine
 * 
 * Generates suggestions for protocol sections
 */

import type { ProtocolSectionId } from './section_schema'

export interface SectionSuggestion {
  id: string
  sectionId: ProtocolSectionId
  type: 'snippet' | 'completion' | 'template' | 'reg_hint'
  title: string
  preview: string
  fullText: string
  source: 'kg' | 'rag' | 'stats' | 'studyflow' | 'rule' | 'local_protocol'
  confidence: number
  referenceIds?: string[]
}

export interface SuggestionContext {
  projectId: string
  sectionId: ProtocolSectionId
  currentText: string
  projectData: {
    compound?: string
    indication?: string
    phase?: string
    design?: string
    endpoints?: string[]
  }
}

/**
 * Generate suggestions for a section
 */
export async function generateSuggestions(
  context: SuggestionContext
): Promise<SectionSuggestion[]> {
  const suggestions: SectionSuggestion[] = []
  
  // Get template suggestions
  const templates = await getTemplateSuggestions(context)
  suggestions.push(...templates)
  
  // Get RAG-based snippets
  const snippets = await getSnippetSuggestions(context)
  suggestions.push(...snippets)
  
  // Get completion suggestions
  if (context.currentText.length > 0) {
    const completions = await getCompletionSuggestions(context)
    suggestions.push(...completions)
  }
  
  // Sort by confidence
  suggestions.sort((a, b) => b.confidence - a.confidence)
  
  return suggestions.slice(0, 10) // Top 10
}

/**
 * Get template suggestions
 */
async function getTemplateSuggestions(
  context: SuggestionContext
): Promise<SectionSuggestion[]> {
  const templates = SECTION_TEMPLATES[context.sectionId]
  if (!templates) return []
  
  return templates.map((template, index) => ({
    id: `template-${context.sectionId}-${index}`,
    sectionId: context.sectionId,
    type: 'template',
    title: template.title,
    preview: template.text.substring(0, 100) + '...',
    fullText: template.text,
    source: 'rule',
    confidence: 0.9
  }))
}

/**
 * Get snippet suggestions from RAG
 */
async function getSnippetSuggestions(
  context: SuggestionContext
): Promise<SectionSuggestion[]> {
  // This would call RAG search on clinical_reference
  // For now, return placeholder
  return []
}

/**
 * Get completion suggestions
 */
async function getCompletionSuggestions(
  context: SuggestionContext
): Promise<SectionSuggestion[]> {
  // This would use OpenAI for inline completion
  // For now, return placeholder
  return []
}

/**
 * Section templates (simplified)
 */
const SECTION_TEMPLATES: Record<ProtocolSectionId, Array<{ title: string; text: string }>> = {
  'objectives': [
    {
      title: 'Primary Objective Template',
      text: `Primary Objective:
To evaluate the efficacy of [COMPOUND] compared to [COMPARATOR] in patients with [INDICATION], as measured by [PRIMARY_ENDPOINT].`
    },
    {
      title: 'Secondary Objectives Template',
      text: `Secondary Objectives:
1. To assess the safety and tolerability of [COMPOUND]
2. To evaluate the effect on [SECONDARY_ENDPOINT_1]
3. To characterize the pharmacokinetic profile of [COMPOUND]`
    }
  ],
  'endpoints': [
    {
      title: 'Primary Endpoint Template',
      text: `Primary Endpoint:
[ENDPOINT_DESCRIPTION] at [TIMEPOINT].

The primary endpoint will be analyzed using [STATISTICAL_METHOD].`
    }
  ],
  'eligibility': [
    {
      title: 'Inclusion Criteria Template',
      text: `Inclusion Criteria:
1. Male or female patients aged 18-75 years
2. Confirmed diagnosis of [INDICATION]
3. [DISEASE_SPECIFIC_CRITERIA]
4. Willing and able to provide informed consent
5. Adequate organ function as defined by laboratory values`
    },
    {
      title: 'Exclusion Criteria Template',
      text: `Exclusion Criteria:
1. Pregnant or breastfeeding women
2. Known hypersensitivity to [COMPOUND] or excipients
3. Significant cardiovascular, hepatic, or renal disease
4. Participation in another clinical trial within 30 days
5. Unable to comply with study procedures`
    }
  ],
  'safety_assessments': [
    {
      title: 'Safety Assessments Template',
      text: `Safety Assessments:

Adverse Events:
All adverse events (AEs) will be recorded from the time of informed consent until 30 days after the last dose of study treatment. AEs will be graded according to NCI CTCAE v5.0.

Serious Adverse Events:
All serious adverse events (SAEs) must be reported to the sponsor within 24 hours of awareness.

Laboratory Assessments:
- Hematology: Complete blood count with differential
- Chemistry: Comprehensive metabolic panel
- Urinalysis: Routine urinalysis

Vital Signs:
Blood pressure, heart rate, respiratory rate, and temperature will be measured at each visit.`
    }
  ],
  'statistics': [
    {
      title: 'Sample Size Template',
      text: `Sample Size Calculation:

The sample size was calculated based on the primary endpoint of [ENDPOINT]. Assuming:
- Type I error (α): 0.05 (two-sided)
- Power (1-β): 0.80
- Effect size: [EFFECT_SIZE]
- Standard deviation: [SD]
- Dropout rate: 15%

A total of [N] patients ([N/2] per arm) will be enrolled.`
    }
  ],
  'title': [],
  'synopsis': [],
  'study_design': [],
  'study_population': [],
  'treatments': [],
  'study_flow': [],
  'efficacy_assessments': [],
  'admin': [],
  'ethics': [],
  'icf_summary': []
}
